78 related articles for article (PubMed ID: 23901273)
21. gH625: a milestone in understanding the many roles of membranotropic peptides.
Galdiero S; Falanga A; Morelli G; Galdiero M
Biochim Biophys Acta; 2015 Jan; 1848(1 Pt A):16-25. PubMed ID: 25305339
[TBL] [Abstract][Full Text] [Related]
22. The Nm23-H1-h-Prune complex in cellular physiology: a 'tip of the iceberg' protein network perspective.
Galasso A; Zollo M
Mol Cell Biochem; 2009 Sep; 329(1-2):149-59. PubMed ID: 19390954
[TBL] [Abstract][Full Text] [Related]
23. gH625 is a viral derived peptide for effective delivery of intrinsically disordered proteins.
Smaldone G; Falanga A; Capasso D; Guarnieri D; Correale S; Galdiero M; Netti PA; Zollo M; Galdiero S; Di Gaetano S; Pedone E
Int J Nanomedicine; 2013; 8():2555-65. PubMed ID: 23901273
[TBL] [Abstract][Full Text] [Related]
24. Peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood-brain barrier in rats.
Valiante S; Falanga A; Cigliano L; Iachetta G; Busiello RA; La Marca V; Galdiero M; Lombardi A; Galdiero S
Int J Nanomedicine; 2015; 10():1885-98. PubMed ID: 25792823
[TBL] [Abstract][Full Text] [Related]
25. Dimerization in tailoring uptake efficacy of the HSV-1 derived membranotropic peptide gH625.
Falanga A; Valiante S; Galdiero E; Franci G; Scudiero O; Morelli G; Galdiero S
Sci Rep; 2017 Aug; 7(1):9434. PubMed ID: 28842580
[TBL] [Abstract][Full Text] [Related]
26. Quantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cells.
Perillo E; Allard-Vannier E; Falanga A; Stiuso P; Vitiello MT; Galdiero M; Galdiero S; Chourpa I
Int J Pharm; 2015 Jul; 488(1-2):59-66. PubMed ID: 25891256
[TBL] [Abstract][Full Text] [Related]
27. Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction.
Carotenuto M; Pedone E; Diana D; de Antonellis P; Džeroski S; Marino N; Navas L; Di Dato V; Scoppettuolo MN; Cimmino F; Correale S; Pirone L; Monti SM; Bruder E; Zenko B; Slavkov I; Pastorino F; Ponzoni M; Schulte JH; Schramm A; Eggert A; Westermann F; Arrigoni G; Accordi B; Basso G; Saviano M; Fattorusso R; Zollo M
Sci Rep; 2013; 3():1351. PubMed ID: 23448979
[TBL] [Abstract][Full Text] [Related]
28. Shuttle-mediated nanoparticle delivery to the blood-brain barrier.
Guarnieri D; Falanga A; Muscetti O; Tarallo R; Fusco S; Galdiero M; Galdiero S; Netti PA
Small; 2013 Mar; 9(6):853-62. PubMed ID: 23135878
[TBL] [Abstract][Full Text] [Related]
29. Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential.
Hope MJ; Bally MB; Webb G; Cullis PR
Biochim Biophys Acta; 1985 Jan; 812(1):55-65. PubMed ID: 23008845
[TBL] [Abstract][Full Text] [Related]
30. Dendrimer functionalization with a membrane-interacting domain of herpes simplex virus type 1: towards intracellular delivery.
Carberry TP; Tarallo R; Falanga A; Finamore E; Galdiero M; Weck M; Galdiero S
Chemistry; 2012 Oct; 18(43):13678-85. PubMed ID: 22968943
[TBL] [Abstract][Full Text] [Related]
31. Pollutant-induced modulation in conformation and β-lactamase activity of human serum albumin.
Ahmad E; Rabbani G; Zaidi N; Ahmad B; Khan RH
PLoS One; 2012; 7(6):e38372. PubMed ID: 22685563
[TBL] [Abstract][Full Text] [Related]
32. Structure and orientation of the gH625-644 membrane interacting region of herpes simplex virus type 1 in a membrane mimetic system.
Galdiero S; Russo L; Falanga A; Cantisani M; Vitiello M; Fattorusso R; Malgieri G; Galdiero M; Isernia C
Biochemistry; 2012 Apr; 51(14):3121-8. PubMed ID: 22397737
[TBL] [Abstract][Full Text] [Related]
33. Intracellular delivery: exploiting viral membranotropic peptides.
Galdiero S; Vitiello M; Falanga A; Cantisani M; Incoronato N; Galdiero M
Curr Drug Metab; 2012 Jan; 13(1):93-104. PubMed ID: 22292812
[TBL] [Abstract][Full Text] [Related]
34. Clickable functionalization of liposomes with the gH625 peptide from Herpes simplex virus type I for intracellular drug delivery.
Tarallo R; Accardo A; Falanga A; Guarnieri D; Vitiello G; Netti P; D'Errico G; Morelli G; Galdiero S
Chemistry; 2011 Nov; 17(45):12659-68. PubMed ID: 21956538
[TBL] [Abstract][Full Text] [Related]
35. A peptide derived from herpes simplex virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dots.
Falanga A; Vitiello MT; Cantisani M; Tarallo R; Guarnieri D; Mignogna E; Netti P; Pedone C; Galdiero M; Galdiero S
Nanomedicine; 2011 Dec; 7(6):925-34. PubMed ID: 21664490
[TBL] [Abstract][Full Text] [Related]
36. Cellular structural biology.
Ito Y; Selenko P
Curr Opin Struct Biol; 2010 Oct; 20(5):640-8. PubMed ID: 20801639
[TBL] [Abstract][Full Text] [Related]
37. Molecular alterations in key-regulator genes among patients with T4 breast carcinoma.
Massidda B; Sini M; Budroni M; Atzori F; Deidda M; Pusceddu V; Perra M; Sirigu P; Cossu A; Palomba G; Ionta M; Palmieri G
BMC Cancer; 2010 Aug; 10():458. PubMed ID: 20735841
[TBL] [Abstract][Full Text] [Related]
38. The presence of a single N-terminal histidine residue enhances the fusogenic properties of a Membranotropic peptide derived from herpes simplex virus type 1 glycoprotein H.
Galdiero S; Falanga A; Vitiello M; Raiola L; Russo L; Pedone C; Isernia C; Galdiero M
J Biol Chem; 2010 May; 285(22):17123-36. PubMed ID: 20348105
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
